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Abstract The Arabidopsis COP9 complex is a multi-subunit
repressor of photomorphogenesis which is conserved among
multicellular organisms. Approximately 12 proteins copurify
with the COP9 complex. Seven of these proteins are orthologues
of subunits of the recently published mammalian COP9 complex.
Four of the proteins show amino acid similarity to various
subunits of the COP9 complex, eIF3 complex and 19S cap of the
proteasome. We have studied one of these proteins in order to
determine if it is a component of the COP9 complex. Arabidopsis
p105 is highly similar to the p110 subunit of the human eIF3. The
p105 gene is induced during photomorphogenesis, and RNA and
protein analysis reveal different tissue accumulation patterns.
p105 is found in a large protein complex. p105 interacts in yeast
with both COP9 and FUS6, two known components of the
COP9 complex. Our results indicate that p105 is not a
component of the COP9 core complex, though it may interact
with components of the complex.
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1. Introduction
Signal transduction pathways respond to numerous signals
to regulate development through di¡erential transcription,
translation and/or post-translational processes. While the sig-
nals are diverse, and the responses speci¢c, these pathways
contain common components and are integrated through so-
phisticated, though largely unknown mechanisms. Maintain-
ing the proper equilibrium between transcription, translation
and post-translational mechanisms is essential for normal de-
velopment.
Large, multi-protein complexes have been found to have
central roles in the regulation of transcription (e.g. TFIID
[1]), translation (e.g. eIF3 [2]) and post-translational processes
(e.g. proteasome [3]). An additional multi-subunit regulatory
protein complex, the COP9 complex, is an essential nuclear-
localized protein complex which has a central role in regulat-
ing development in plants, and most likely in animals as well
[4]. Arabidopsis mutants lacking the COP9 complex have a
variety of pleiotropic phenotypes most evident in the loss of
light regulation of seedling development. Various genetic stud-
ies showed that the complex functions as a downstream re-
pressor of photomorphogenic growth patterns in darkness
[5,6]. However, the complex has a larger role beyond media-
ting the light control of plant development: mutations in the
COP9 complex are lethal following the seedling stage [5,7] ;
transcription of several other groups of genes may be misre-
gulated in these mutants [8] ; and the complex is conserved
between plant and animal systems [9^11].
In spite of the central role for the COP9 complex in devel-
opmental regulation, its biochemical activity remains elusive.
A major breakthrough in the study of the COP9 complex has
been its puri¢cation from cauli£ower [12]. Through an empir-
ically derived puri¢cation strategy based on an immuno-assay
for COP9 protein, we showed that the COP9 complex is neg-
atively charged, binds heparin and has multiple subunits. The
puri¢cation of the COP9 complex identi¢ed FUS6, which is
encoded by an additional photomorphogenic locus in Arabi-
dopsis, as a component of the complex.
Recent reports have highlighted the similarities between the
COP9 complex, eIF3 complex and the 19S regulatory complex
of the proteasome. All three complexes are multi-subunit and
similar in size and subunits of all three complexes share a
similar motif, termed the PCI (Proteasome-COP9 complex-
Initiation, [13]) or PINT (Proteasome-Int6-Nip1-Trip15 [14])
domain. A protein family based on one of the subunits of the
COP9 complex, the FUS6 family of proteins [9], includes
components of all three protein complexes. While the biolog-
ical signi¢cance of the PCI/PINT domain is still unknown, the
domain, together with the other similarities, suggests that
there may be some form of interaction between these com-
plexes, or shared subunits between the complexes.
We report here the identi¢cation, based on peptide se-
quence data, of the proteins which copurify with the COP9
complex and the cloning of the gene for one of these proteins.
Our data suggest that this protein associates with the COP9
complex, though not as a member of the core complex, and
that it may have a role as a member of the eIF3 complex.
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2. Materials and methods
2.1. Peptide sequencing
Proteins copurifying with the COP9 in the COP9 complex were
isolated and peptide sequenced as described [12].
2.2. Plant materials and growth conditions
The cop9-1 and fus6 mutants are in Wassilewskija (Ws) back-
ground. Plant germination and growth conditions in darkness and
white light were as described [5,15]. Light/dark cycle conditions of
16 h of white light at 75 Wmol m32 s31 and 8 h of darkness was
used for light-grown seedlings.
2.3. Isolation of Arabidopsis p105 cDNA clones
The cauli£ower peptide sequence from P71 matches 8 amino acids
in the Arabidopsis EST clone 210I18T7 (accession number N37787).
This partial cDNA clone was used to obtain the full-length cDNA
clone from VZAPII Arabidopsis size fractionated cDNA library [16]. A
DIG labeled (Boehringer Mannheim) DNA probe was generated us-
ing the EST as template. For cDNA screening, 5U105 phages dis-
played on duplicate sets of ¢lters (positively charged nylon mem-
branes, Boehringer Mannheim). Prehybridization, hybridization and
¢lter washings were according to standard DIG procedure at 68‡C
(Boehringer Mannheim). Positive clones were excised in vivo accord-
ing to standard procedure. PCR analysis was performed on the ¢rst
round plaque picks in order to select the longest cDNA clone. A
speci¢c primer from the EST coding region and the T7 promoter
were used. Among the plaques screened, 12 positives were identi¢ed.
Two clones were chosen for further analysis, pDC121.1, which con-
tains a 1600-bp cDNA, corresponding to the 2/3 carboxyl region of
p105, and the longest clone named pDCBK5, which contains the full
coding region.
2.4. Antibody production
The insert in pDC121.1 was cloned into pGEX5x-2 (Pharmacia).
The E. coli overexpressed GST-fusion protein was insoluble. The 2k
centrifugation pellet containing the fusion protein in inclusion bodies
was separated through an 8% PAGE gel, and the fusion protein ex-
cised and used to immunize rabbits (AniLab, Rehovoth, Israel). For
a⁄nity puri¢cation of the resulting serum, a fragment of p105 was
expressed in pET29b (Novagen). The expressed protein was solubi-
lized from inclusion bodies by 1% N-lauroylsarcosine and immobilized
on an NHS-activated column (Pharmacia). Anti-p105 anitbodies were
puri¢ed as described [6].
2.5. Protein extraction, gel ¢ltration chromatography, and immunoblot
analysis
Plant tissues were homogenized and proteins analyzed as described
[12] except that proteins were separated on 8% SDS-PAGE gels. The
protein gels were transferred onto polyvinylidene di£uoride (PVDF)
membranes, and probed with a⁄nity-puri¢ed polyclonal antibodies
against p105. Protein extraction and conditions for gel ¢ltration chro-
matography were as described [6,12] with the following modi¢cations:
100 Wg of total soluble protein was fractionated through a Superose 6
column (Pharmacia), with extraction bu¡er at a £ow rate of 0.3 ml/
min; fractions of 0.5 ml each were collected and concentrated by
binding to Strataclean resin (Stratagene). An equal volume of individ-
ual fractions was used for immuno-blot analysis.
2.6. RNA analysis
Total RNA was isolated using Trizol (Gibco-BRL). Equal amounts
of total RNA (2.5 Wg per lane) were electrophoresed on a 1% agarose/
formaldehyde gel for 3.5 h at 50 V. RNA was blotted to positively
charged nylon membrane (Boehringer Mannheim) and UV cross-
linked. Hybridization was conducted using the insert in pDC121.1
as a riboprobe in 50% formamide, 2% blocking reagent (Genius;
Boehringer Mannheim), 5U SSC, 0.02% SDS, 0.1% N-lauroylsarco-
sine at 68‡C. An antisense riboprobe corresponding to the pDCBK5
clone was generated using SP6 RNA polymerase with non-radioactive
digoxigenin dUTP and detected with chemiluminescent substrate
(CSPD; Boehringer Mannheim). For size standards, an RNA ladder
was used (Boehringer Mannheim). The blot was reprobed with 18S
rRNA which served as a control for equal loading.
2.7. Yeast two-hybrid assay
The insert in pDC121.1 was cloned into EcoRI site of pEG202 to
make in-frame fusion with LexA. The generated plasmid was desig-
nated pEG-P105. Yeast strain EGY48-0 [17] was transformed with a
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Table 1
Analysis of proteins copurifying with COP9




71 DHVMAATR This work eIF3-p110 Yeast NIP1
56 RYGDLFLRQIAK ^ ^ ^
52 ILYARHADQRNATFQK FUS6 COPS1, GPS1 ^
ELEALLITDNQIQARIDSHNK FUS6 COPS1, GPS1
SLYHTEDAPQDMVERRAEVVARLK FUS6 COPS1, GPS1
50 ASFLVNSSQNEVLNLQYK EST T45438 COPS4 ^
48 IDSESGTVIMEPTQPNVHEQLINHTK EST T75664 INT6 Similar to COPS2
VIQQEHYSYK EST T76471 INT6
LVTQLLEHSQGQAAR INT6
SLYHTEDAPQDMVERRAEVVARLK EST T43721 INT6
44 DGMVRFLEDPEQYK ^ COPS3 Tomato LC15
EAEMHVLQMIQDGQIHALINQK ^ COPS3 Tomato LC15
KNERLWFK ^ COPS3 Tomato LC15
43 LFEEGGDWERK EST N95941 FUS6-like
IADAEENLGESEVREAHLK EST N95941 FUS6-like
42 SSLDSHLLDLLWNK AJH1 COPS5, JAB1
VEQPDSSSSDGIFYYDEASQTK AJH1 COPS5, JAB1
41 FQYYYRNLSRQQAQQQAWLQK EST N96623 ^ MOV34-Protein
36 ALL(E/P)QVSVL Putative protein g2982463 COPS6
KLGPLVIVM g2982463 COPS6
27 LFAHGTWGDYK ^ COPS7 AcoB
QAEIIDQLVR ^ COPS7 AcoB
KCNASRIPQLSPDQILK ^ COPS7 AcoB
QLTVLTLAESNK ^ COPS7 AcoB
22 LWTRDYAGVYEAIRGFDWSQDAK COP9 HCOP9
For each protein, peptide sequences were determined as described [12]. These data are cumulative from three separate COP9 complex preparations.
Some peptides were sequenced more than once. If a protein has been reported under more than one name, both are given. ^, None detected. eIF3-
p110 [22], NIP1 [21], FUS6 [7], COPS1-7 [11], GPS1 [41], INT6 [42], tomato LC15 (U19099), AJH1 [18], JAB1 [39], AcoB [43], COP9 [6], HCOP9
[9].
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combination of 3 plasmids: a bait (pEG-P105), a prey (pJG-COP9 or
pJG-FUS6, [18]), and a reporter (pSH18-34), according to [19]. Col-
onies were selected on synthetic complete media without histidine,
tryptophan and uracil. A L-galactosidase activity assay of the trans-
formants was performed using o-nitrophenyl-L-D-galactoside, accord-
ing to [20]. Relative activity units were calculated according to [17].
2.8. Multiple sequence alignments
Amino acid sequences were aligned with ClustalX.
3. Results
3.1. Peptide sequencing of proteins copurifying with the
COP9 complex
Towards our goal to de¢ne the biochemical activity and the
subunit composition of the COP9 complex, a breakthrough in
the analysis of the complex was its biochemical puri¢cation
from cauli£ower [12]. Putative subunits of the puri¢ed com-
plex were separated by SDS-PAGE, and individual protein
bands were excised and subjected to amino acid sequencing.
Over 30 peptides corresponding to the 10 proteins copurify-
ing with COP9 and FUS6 in the COP9 complex were se-
quenced. As shown in Table 1, these peptide data have al-
lowed us to identify the identity of the majority of these
proteins. p22 and p52 were previously shown to be COP9
and FUS6, respectively [12]. Five additional proteins, p27,
p36, p42, p44, and p50, are highly similar to ¢ve other sub-
units of the recently published mammalian COP9 complex
[10,11]. In total we identi¢ed in our preparations seven of
the eight subunits of the mammalian COP9 complex.
Four other proteins which copurify with the COP9 com-
plex, p41, p43, p48 and p71, appear to be the cauli£ower
orthologues of four PCI/PINT motif containing proteins.
p41 is a member of the MOV34 family, which is also similar
to subunits of the COP9 complex, proteasome and eIF3; p43
is a member of the FUS6 family of proteins; p48 is highly
conserved with INT6, which is proposed to be a member of
the eIF3 complex, but is also very similar to the mammalian
COP9 complex subunit 2; p71 is the cauli£ower orthologue of
the human p110 subunit of eIF3. No proteins were found to
be similar to the peptide sequence of p56.
The presence of these four proteins in our COP9 complex
preparations may be a result of non-speci¢c copuri¢cation.
On the other hand, the recent discovery of the PCI/PINT
family of proteins suggests that there may also be a functional
relationship between subunits of the COP9 complex, eIF3
and the 19S regulatory subunit of the proteasome. In
order to clarify this matter, we have concentrated this study
on de¢ning the relationship between p71 and the COP9 com-
plex.
3.2. Cloning and characterization of p105 cDNA
The 8 amino acid peptide sequence of p71, DHVMAATR,
was used to search the Arabidopsis cDNA sequence database.
The predicted gene product of one expressed sequence tag
(EST) cDNA clone was found to contain the exact same 8
amino acid sequence. A DIG labeled RNA probe derived
from the EST clone was generated and used in a Northern
analysis on total Arabidopsis RNA. A single RNA band mi-
grating at 3.1 kb hybridized with the probe, indicating that
the full length cDNA is longer than the EST. To obtain the
full length cDNA sequence, an Arabidopsis cDNA library was
screened with a DNA probe derived from the same EST, and
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Fig. 1. A: Amino acid sequence of p105. The three predicted coiled-coil regions are underlined. Charged residues in the amino terminus are
shown in white on black background. Uncharged, polar amino acid residues in the carboxyl terminus are shown with a light gray background.
The domain conserved among a number of RNA binding proteins is boxed. B: Schematic structure of p105. The ¢rst methionine is noted
(MET) as are the coiled-coil regions (CC) and PCI domain. Secondary structures were predicted using the PHD server [40].
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the longest cDNA clone found was sequenced on both strands
as described in Section 2.
pDCBK5 contains a 2925-bp insert with an open reading
frame that encodes a hydrophilic protein of 900 amino acids
with a calculated mass of 102 787 Da and a pI of 5.01. The
amino acid sequence derived from the open reading frame is
shown in Fig. 1. A BLAST search for proteins similar to p105
indicates that it shares a 31% amino acid identity with human
p110, which is a subunit of the eIF3 complex, and 28% iden-
tity with the yeast NIP1 protein, as well as predicted proteins
from C. elegans and S. pombe (Table 2). Although NIP1 was
identi¢ed initially as a protein involved in nuclear import [21],
more recent evidence suggests that it may have a role in trans-
lation, though its connection to eIF3 is controversial [22,23].
The identity of p105 with p110 and NIP1 is highest in the
second half of the protein. While the amino half of the protein
is more divergent, the hydrophilic nature of the protein is
highly conserved.
The primary sequence of p105 indicates that, excluding the
amino and carboxyl termini, it is comprised almost entirely of
K-helical structures, with three putative coiled-coil domains
which may be involved in protein-protein interactions.
Twenty-four of the ¢rst 60 amino acids are charged, and a
search of the available databases with this region identi¢es a
number of transcription factors and nuclear RNA binding
proteins. The carboxyl terminal region is comprised of un-
charged, polar amino acids. This region identi¢es in the data-
bases a number of glycine rich RNA binding proteins. p105
also contains a PCI domain and is a member of the FUS6
family of proteins (Fig. 1B).
In order to determine if p105 is a member of the COP9 core
complex, we employed several approaches. Antibodies were
raised against the COOH-terminal portion of the cDNA car-
rying about 66% of the coding region, and a⁄nity puri¢ed as
described in Section 2. The a⁄nity-puri¢ed anti-p105 antibod-
ies recognize a protein of 105 kDa in total Arabidopsis pro-
teins and proteins of 105 and 70 kDa in samples of the par-
tially puri¢ed COP9 complex from cauli£ower (not shown). It
is not clear if p71 is a speci¢c or non-speci¢c degradation
product of P105.
3.3. p105 is present in mutants lacking the COP9 complex
Known subunits of the COP9 complex have di¡erent accu-
mulation patterns in mutants lacking the complex. COP9 and
FUS6 proteins are absent in mutants lacking the COP9 com-
plex [6,24] while p42 (= AJH proteins) is present in these mu-
tants [18]. As shown in Fig. 2A, p105 is present in cop9 mu-
tants which lack the COP9 complex. However, the amount of
p105 in cop9 and fus6 is reduced relative to the wild type. This
result suggests that while p105 may be in£uenced by the
COP9 complex, it also has a role beyond the complex.
3.4. p105 is found in a large protein complex
In order to determine if p105 is found as a large molecular
weight species, total soluble proteins from Arabidopsis were
separated by gel ¢ltration chromatography, and the fractions
subjected to Western blot analysis with anti-p105 antibodies.
As shown in Fig. 2B, p105 is found in a large molecular
weight species of about 750 kDa, but it is also present in
the 500-kDa fractions. In partially puri¢ed complex fractions
from cauli£ower, the elution pro¢le of p105 overlaps that of
other COP9 complex components (not shown).
3.5. Expression patterns of p105
To examine the possible light regulation of p105 expression,
total RNA or protein from 4-day-old dark and light-grown
wild-type seedlings was isolated and subjected to gel blot anal-
ysis with the p105 riboprobe or p105-speci¢c antibodies. The
abundance of p105 transcript and protein, similar to FUS6, is
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Fig. 2. A: p105 in wild-type and mutant strains. Strataclean beads
(Stratagene) were added to 280 Wg of total protein, and the pelleted
protein/bead mixture was separated on an 8% polyacrylamide gel.
B: Gel ¢ltration analysis of p105. Equal volumes of protein for
each fraction were separated on an 8% polyacrylamide gel, trans-
ferred to a PVDF membrane and reacted with anti p105 antibodies.
No p105 monomer was detected (not shown).
Table 2
Comparison of Arabidopsis p105, human eIF3-p110, yeast NIP1, and putative gene products from C. elegans and S. pombe
% Identity % Similarity
Arabidopsis Human S. cerevisiae C. elegans S. pombe
Arabidopsis ^ 45.3 30.9 45.1 36.4
Human 32.9 ^ 32.0 41.9 41.7
S. cerevisiae 28.1 20.2 ^ 32.0 39.8
C. elegans 32.3 37.0 20.0 ^ 37.3
S. pombe 25.5 28.6 26.8 23.3 ^
Pairwise amino acid identity is shown in the lower left part of the table, while pairwise amino acid similarity is shown in the upper right half of the
table. % identity and similarity were determined following multiple sequence alignment with ClustalX.
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higher in light-grown than in dark-grown seedlings (Fig. 3A)
[7]. p105 protein levels reach maximal levels within one hour
of deetiolation, while the transcript levels increase up to two
hours of deetiolation.
To determine the tissue expression pattern of p105 in Ara-
bidopsis, we hybridized a p105 riboprobe to total RNA from
organs from adult plants. The blot shown in Fig. 3B reveals
that the p105 transcript is present in all tissues, however, as
was previously found for COP9 and FUS6 [24,25], p105 tran-
script preferentially accumulates in £oral and root tissues. The
accumulation pattern of p105 protein in di¡erent tissues does
not mimic that of the p105 transcript, as p105 protein accu-
mulates at higher levels in green vegetative tissues such as
leaves and stems.
3.6. p105 interacts directly with COP9 and FUS6 subunits
of the COP9 complex
To substantiate the hypothesis that p105 speci¢cally inter-
acts with the COP9 complex, we examined the possibility that
p105 interacts directly with one or more subunits of the com-
plex in a heterologous system. To this end we have used the
yeast two-hybrid assay. p105, FUS6 and COP9 were fused to
either the LexA DNA binding domain (bait) or the yeast
transcription activation domain (prey). If the bait and prey
interact, the reporter lacZ gene which contains the LexA bind-
ing site in its promoter, will be activated. As shown in Fig. 4,
p105 alone does not interact with the activation domain nor
do the COP9 and the FUS6-AD fusions interact with LexA
domain. However, the LexA-p105 fusion protein clearly inter-
acts with both the COP9 and FUS6 proteins in yeast. The
expression of the reporter genes was dependent upon growth
on galactose containing medium, indicating that the expres-
sion of p105 is required for expression of the reporter genes.
4. Discussion
We describe here the identi¢cation of proteins which
copurify with the COP9 complex, and the cloning of a new
Arabidopsis gene which encodes one of these copurifying pro-
teins. While our original goal was to elucidate the subunit
structure of the COP9 complex, the results presented here
indicate that the determination of this exact subunit compo-
sition of the COP9 complex may be more complicated.
We originally detected 10 proteins which copuri¢ed in equi-
molar ratios with COP9 and FUS6 [12]. Based on peptide
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Fig. 4. P105 interacts with both COP9 and FUS6 in the yeast two-
hybrid assay. The relative LacZ reporter gene activity in yeast cells
for the di¡erent combinations of plasmids is shown. LacZ activity
in the negative control represents the background levels in yeast
cells. Ten individual transformants were used to measure relative
LacZ activity for each pairwise combination. Error bars represent
standard deviation. AD: activating domain.
Fig. 3. Expression patterns on p105. A: p105 is induced during dee-
tiolation. Total RNA or proteins were separated by gel electropho-
resis and probed with either a p105 riboprobe (for RNA analysis)
or anti-p105 antibodies (for protein analysis). The peak seen in
p105 RNA after 2 h is due in part to unequal RNA loading as de-
termined by the 18S rRNA amounts. B: Tissue speci¢city of p105.
Equal amounts of RNA were loaded according to 18S rRNA (not
shown). For protein analysis, Strataclean beads were added to 100
Wg of soluble protein, concentrated and run on an 8% polyacryl-
amide gel. F = £ower, L = leaf, S = stem, R = roots.
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sequence data, seven of these proteins are likely orthologues
of the subunits of the mouse COP9 complex. The identi¢ca-
tion of these proteins indicates that our initial preparation was
highly enriched with COP9 complex and identi¢es a high level
of conservation, both at the level of amino acid sequence, and
at the level of complex composition, between the plant and
animal COP9 complexes. While we have not identi¢ed a pro-
tein highly similar to the S2 subunit of the animal complex,
this protein was identi¢ed in the a⁄nity puri¢ed COP9 com-
plex from Arabidopsis [11]. However, we have also identi¢ed
several proteins which show similarities to components of
eIF3 and the 19S cap of the proteasome. While eIF3, the
19S cap of the proteasome and the COP9 complex are similar
in size and contain subunits which may be evolutionarily re-
lated, each complex has unique biochemical properties and
di¡erent biological functions.
The p105 protein which copuri¢es with the COP9 complex
is very similar to the p110 subunit of the human eIF3 com-
plex. The proteins are similar in size and share 30% amino
acid identity over the entire length of the protein. As the
COP9 complex and eIF3 complex may be similar in size
and in charge, it is plausible that p105 is found with the
COP9 complex as a contaminant of copurifying eIF3. How-
ever, several lines of evidence suggest that p105 speci¢cally
interacts with the COP9 complex and that its puri¢cation is
not simply a result of non-speci¢c copuri¢cation:
1. p105 copuri¢es with the COP9 complex in an equimolar
ratio with COP9 and FUS6 [12].
2. The expression pattern of p105 is similar to that of other
components of the complex.
3. p105 contains a PCI/PINT motif common to COP9
complex components.
4. p105 interacts in yeast with both COP9 and FUS6, two
known components of the COP9 complex. This interac-
tion appears speci¢c as (i) p105 by itself does not acti-
vate the yeast assay; (ii) while both COP9 and FUS6 are
also PCI/PINT containing proteins, they do not interact
with each other and share little if any amino acid sim-
ilarity; (iii) p105 does not interact with additional com-
ponents of the complex, such as p27 (Karniol and Cha-
movitz, unpublished). Taken together these results
suggest that p105 is not simply a ‘sticky’ protein and
that the interaction of p105 with COP9 and FUS6 in
yeast is speci¢c.
5. If p105 is a component of a copurifying eIF3, we would
expect that other components of eIF3 would be found in
our COP9 complex preparations. However, as shown in
Table 1, only one other homologue of eIF3 copuri¢es
with the COP9 complex, p48/INT6. Other known sub-
units, such as PRT1, clearly do not copurify with the
COP9 complex (our own unpublished results). While
INT6 is postulated to be a member of eIF3 [26], it
also has an additional nuclear function [27], also con-
tains a PCI/PINT domain [14], and is similar to the S2
subunit of the mammalian COP9 complex [11]. Thus it is
plausible that p48/INT6 also interacts with the COP9
complex.
While the evidence presented above suggests that p105 spe-
ci¢cally associates with components of the COP9 complex,
other evidence indicates that p105 itself is not an integral
component of the COP9 core complex. The presence of
p105 in cop9 mutants indicates that p105 has a function out-
side the complex. Furthermore, p105 is not present in the
stringent a⁄nity-puri¢ed preparation of the COP9 complex
from Arabidopsis based on binding of the complex to anti-
FUS6 [11], nor is its human orthologue, p110, present in
the recently reported human COP9 complex [10,11]. However,
a⁄nity puri¢cation is much more stringent than biochemical
puri¢cation as it includes multiple detergents in the procedure
which may wash o¡ loosely associated proteins. Indeed, in
initial puri¢cations of proteasome complexes, what were later
identi¢ed as components of these complexes were lost due to
over-stringent conditions [28]. Furthermore, we do not know
the size of the immuno-puri¢ed complex, as it is released from
the antibodies under denaturing conditions. It is thus possible
that p105 is lost at this stage. In addition, the size of the
human complex, 450 kDa, is less than that reported for the
plant complex, 550 kDa, so the plant complex may contain
additional subunits.
How then do we reconcile the presence of p105 in both
eIF3 and the COP9 complex? While the p105 human homo-
logue p110 has been shown to copurify with eIF3, the subunit
composition of eIF3, and the size of the complex itself, is
controversial in higher eukaryotes [22,29^31] and yeast [32^
34]. Various reports have placed the size of eIF3 between 550
and 700 kDa [2,35^37]. The Arabidopsis p105 elutes from a gel
¢ltration column as a large protein complex of 750 kDa. In
yeast, NIP1 is the protein most similar to human eIF3 p110;
it is therefore the most likely candidate for a yeast eIF3-p110
orthologue. However, a biochemically active yeast eIF3 prep-
aration appears not to contain NIP1 [32], suggesting that
NIP1 plays an alternative role. In lieu of an in vitro recon-
stitution of eIF3 activity, it is premature to determine the
exact relationship of p110/NIP1 to eIF3 [22]. Whether the
plant eIF3 contains p105 or another NIP1-like protein is
not known.
Alternatively, p105 may participate in multiple protein
complexes, such as eIF3 and the COP9 complex. One possi-
bility may be that p105 ful¢lls a structural role in the com-
plexes. The primary structure of p105 suggests that it may
interact with multiple proteins through its di¡erent coiled-
coil domains.
Several ¢ndings indicate that the COP9 complex or COP9
complex components may exist in di¡erent forms. First, at
least two subunits of the mammalian COP9 complex, and
one subunit of the human eIF3 complex are known to have
roles outside of their respective complexes. The mammalian
COP9 complex subunit S2/SGN2 is also known as TRIP15, a
protein associated with the nuclear thyroid hormone receptor
[38]. Subunit S5/SGN5 is JAB1, a protein originally isolated
through its interaction with JUN [10,39]. The eIF3 subunit
p48 is also known as INT-6, a protein associated with the
PML protein in nuclear bodies [27]. So while eIF3 has a
proposed cytoplasmic role in translational regulation, INT6
also has a nuclear function. Second, the gel ¢ltration proper-
ties of the COP9 complex appear to be light dependent with a
larger complex appearing in etiolated seedlings [6]. Third,
non-denaturing gel electrophoresis indicated that the human
COP9 complex is found in multiple forms ranging from 450 to
1000 kDa [10].
Considering these ¢ndings, a proposed role for p105 in both
the COP9 complex and eIF3 is not too far fetched. An ap-
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pealing, though as yet untested, model would have the COP9
complex interacting with both the proteasome and eIF3 to
modulate development. p105 may mediate the interaction be-
tween eIF3 and the COP9 complex. Future studies should
concentrate on underpinning the domains of p105 responsible
for its interaction with the COP9 complex, identify compo-
nents of eIF3 which interact with p105, and determine the
subcellular localization of p105.
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